What is ANZRAP
The Australia and New Zealand Respiratory Audit Program (ANZRAP) is a long-term research and quality improvement program to improve the quality of care, clinical outcomes and health service provision for people with chronic obstructive pulmonary disease (COPD) and asthma in Australia and New Zealand. We will benchmark our findings against national and international standards and co-design solutions for local quality improvement.
Our Aims
ANZRAP aims to provide comprehensive data on COPD and asthma care in Australia and New Zealand to:
- Understand prevalence and risk factors for exacerbations & hospitalisations,
- Examine healthcare provision, quality of care, and clinical outcomes,
- Explore variations in healthcare,
- Examine how health care is provided and by whom,
- Benchmark current care against national and international standards.
Our Goals
ANZRAP will describe the current quality of care, including but not limited to access, availability and timeliness of care received by people admitted with exacerbations of COPD or asthma. We will identify gaps in clinical care delivery against quality indicators described in current and emerging clinical care standards. This work will support and inform future quality improvement projects.
Our Research Program
ANZRAP will collect data across three key areas:
- Adults admitted with an exacerbation of COPD (commencing 2025)
- Adults admitted with an exacerbation of asthma (commencing 2026)
- Health services’ structure and workforce capacity (commencing in 2025).
Contact Us
If you would like to become an ANZRAP site or further information, please email any of:
Australia ANZRAP Chair:
Prof Natasha Smallwood: [email protected]
New Zealand ANZRAP Chair:
Dr James Fingleton: [email protected]
ANZRAP Project manager:
Dr Lena Ly: [email protected]
